☆
Exploring Corresponding Cutpoints for Hypoglycaemia Awareness Questionnaire (HypoA‐Q) Impaired Awareness Subscale in Relation to the Gold and Clarke Measures: A Post Hoc Analysis From the Hypo‐METRICS Study
Vaios Koutroukas,
Aikaterina Tziannou,
Uffe Søholm,
Jonah J. C. Thomas,
Gilberte Martine‐Edith,
Simon Heller,
Julia K. Mader,
Ulrik Pedersen‐Bjergaard,
Bastiaan E. de Galan,
Eric Renard,
Mark L. Evans,
Rory McCrimmon,
Frans Pouwer,
Stephanie A. Amiel,
James A. M. Shaw,
Jane Speight,
Pratik Choudhary,
the Hypo‐RESOLVE Consortium,
Andrew Pernet,
Amy Aldridge,
Marcia Henderson‐Wilson,
Pernille Banck‐Petersen,
Rikke Carstensen,
Charlotte Hansen,
Sharon Caunt,
Sue Hudson,
Ch
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
ABSTRACT Aims The Hypoglycaemia Awareness Questionnaire–Impaired Awareness subscale (HypoA‐Q/IA) was developed to enhance impaired awareness of hypoglycaemia (IAH) assessment, addressing methodological deficiencies of the established...
☆
Glucagon‐Like Peptide‐1 Receptor Agonists in Type 1 Diabetes: The Importance of Identifying the Insulin‐Resistant Type 1 Diabetes Phenotype, and Differentiating Early and Newer Generation Therapies
Jerry R. Greenfield,
Ruth Frampton,
Jennifer R. Snaith
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Semaglutide, Tirzepatide and Clinically Recorded Alcohol‐Related Outcomes in Type 2 Diabetes: A Target Trial Emulation
Huilin Tang,
Bingyu Zhang,
Ying Lu,
Yiwen Lu,
Haoyuan Wang,
Christal N. Davis,
Henry R. Kranzler,
Yong Chen
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
ABSTRACT Aims To compare the risk of incident alcohol use disorder (AUD) among adults with Type 2 diabetes (T2D) initiating semaglutide, tirzepatide or sodium‐glucose cotransporter‐2 inhibitors (SGLT2i). Materials and Methods We...
☆
Dose–Exposure–Response Analysis of Finerenone on Serum Potassium and Cardiovascular Outcomes Among Patients With Heart Failure: Insights From FINEARTS‐HF
Thomas Eissing,
Finnian R. Mc Causland,
Muthiah Vaduganathan,
Sebastiaan C. Goulooze,
Eleonora Marostica,
Jan Berkhout,
Paul van den Berg,
Nelleke Snelder,
Dirk Garmann,
Joerg Lippert,
Meike Brinker,
Brian L. Claggett,
John J. V. McMurray,
Scott D. Solomon
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
ABSTRACT Background Finerenone reduces the risk of heart failure and cardiovascular (CV) death among patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF). Whether the effects of finerenone to...
☆
Closed‐Loop Insulin Delivery in Inpatient Care: A Systematic Review and Meta‐Analysis of Clinical and Implementation Outcomes
Vaynika Gupta,
Amanda Ling Jie Yee,
Eleni Armeni,
Kalyaani Persad,
Aspasia Manta,
Punith Kempegowda
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
ABSTRACT Aims Closed‐loop (CL) insulin delivery systems have transformed outpatient diabetes care. However, evidence supporting their role in inpatient settings is limited. This systematic review and meta‐analysis evaluated the safety,...
☆
Therapeutic Signals Without Histologic Certainty: FGF Analogues in Compensated MASH Cirrhosis—A Systematic Review and Meta‐Analysis
Abdulkareem Jomaa,
Mohammed Alani,
Bilind Ismail,
Dani Hayder,
Rani Bshara,
Rafil Bshara,
Wasim Jomaa,
Abdullah Al‐Ibraheem,
Hasan Al‐Obaidi,
Hrishikesh Samant
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
ABSTRACT Background and Aims Compensated MASH cirrhosis is an advanced disease with no current approved pharmacologic therapy. FGF analogues have shown biological activity, but individual trials have not established histologic efficacy....
☆
Prevalence of Chronic Complications After Inaugural Admission in Intensive Care Unit for Type 1 Diabetes in the SFDT1 Cohort: The INAUGURAL Study
Emmanuel Cosson,
Gloria Aguayo,
Amandine Créquer‐Grandhomme,
Amar Bahloul,
Eric Renard,
Louis Potier,
Pauline Schaepelynck,
Agnès Sola‐Gazagnes,
Anne Spiteri,
Jean‐Pierre Riveline,
Guy Fagherazzi
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Accuracy and Safety of the LinX Continuous Glucose Monitoring System in Adults With Diabetes: A Prospective Multicentre Open‐Label Clinical Performance Study
Yang Liu,
Yulong Chen,
Yimei Chen,
Xiaohong Jian,
Xingguang Zhang,
Yufeng Li,
Weiwei Zhu,
Jing Shen,
Yiming Mu
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Diabetes, Obesity and Metabolism
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Comparative Effectiveness of GLP‐1RAs, SGLT2is and DPP4is for Cardiovascular Outcomes in Type 2 Diabetes: An Empirically Calibrated Target Trial Emulation Study
Bingyu Zhang,
Ting Zhou,
Huilin Tang,
Yiwen Lu,
Dazheng Zhang,
Jiajie Chen,
Tianchu Lyu,
Kai Zheng,
David A. Asch,
Yong Chen
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Potential Associations Between GLP‐1 Receptor Agonists and Polyendocrine Metabolic Ovarian Syndrome: Triangulation of Genetic and Pharmacovigilance Evidence
Zeying Feng,
Huilin Lian,
Chong Liu,
Yingmei Shi,
Chenjie He,
Shu Li,
Qiuyan Liang,
Jingjing Li
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Urban Burden Index–Multidomain Assessment of Integrated Obesogenic Risk (UBI‐MAIOR) and Obesity Prevalence Across 10 Metropolitan Areas: An Exploratory Pilot Analysis
Amanda Belluzzi,
Paolo Sbraccia,
Maurizio De Luca,
Ricardo V. Cohen,
Valeria Guglielmi,
Matteo Monami
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Glucagon‐Like Peptide‐1 Medicines and Risk of Dysaesthesia: A Systematic Review, Meta‐Analysis and Meta‐Regression of Randomised Controlled Trials
Ronald M. Goldenberg,
Christine Ibrahim,
Jill Trinacty
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Glucagon‐Like Peptide‐1 Receptor Agonist Use Is Associated With Improved Lung Function in Cystic Fibrosis‐Related Diabetes
Luke A. Ephraums,
Edward R. Mignone,
Kylie Lange,
Ashlee Routley,
Judith Morton,
Emily Hopkins,
Sally Chapman,
Lucia Gagliardi,
Michael Horowitz,
Mahesh M. Umapathysivam
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Trends in GLP‐1‐Based Therapy Use Before and After Pregnancy
Nansi S. Boghossian,
Lauren McAbee,
Antonio F. Saad,
Maged M. Costantine,
Marwan Ma'ayeh,
Joseph A. Ewing
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Pre‐Bedtime Whey Protein Ingestion Increases Blood Glucose Overnight in Adults With Type 1 Diabetes
Sam Zhao,
Giang M. Dao,
Cara Schofield,
Sara Vogrin,
Declan T. Hennessy,
Carmel E. Smart,
Dessi P. Zaharieva,
David N. O'Neal,
Clinton R. Bruce,
Greg M. Kowalski,
Dale J. Morrison
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Beyond Weight Loss: The Challenge of Stopping Obesity Management Medications
Mohammad Kermansaravi,
Ricardo V. Cohen
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
A Multicentre Study of Prevalence and Risk Factors of Diabetic Retinopathy in Children and Young People With Type 1 Diabetes in the United Kingdom
Darren J. C. Toh,
Satish Hulikere,
Rabia Mufti,
Mary Masoud,
Alison Timmis,
Ellie Pearce,
Pooja Sachdev,
Iqra Zameer,
Swathi Upadrasta,
Ramneek Kaur Manku,
Astha Soni,
Sze May Ng
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Effect of Sotagliflozin on Kidney Function and Cardio‐Kidney‐Metabolic Parameters Across Baseline eGFR Subgroups in Patients With Type 2 Diabetes and Stage 4 CKD
Vikas S. Sridhar,
Luxcia Kugathasan,
Manon Girard,
Michael J. Davies,
David Z. I. Cherney
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Distinguishing Biology From Clinical Surveillance in Postpartum Biomarker Trajectories After Gestational Diabetes
Yating Xie,
Jingyuan Li,
Ting Ye
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Weight Loss Is Not Surgical Readiness: The Missing Operative Phenotype in GLP‐1 Body‐Composition Assessment
Damiano Tambasco,
Federica Tomaselli,
Roberta Albanese
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04
☆
Defining Weight‐Loss‐Independent Hepatic Effects of Incretin‐Based Therapies
Mingyuan Zhang,
Hanyang Liu,
Yawen Hao,
Lanlan Chen
Diabetes, Obesity and Metabolism
· Эндокринология, диабет и метаболизм
· 2026-11-04